Presented by
Management Forum

Inhaled Drug Delivery

An essential annual update for inhalation professionals.

Find out more

  • Format: Bespoke training
  • CPD: 12 hours for your records (depending on your requirements)
  • Certificate of completion

Conference Overview

This seminar includes presentations and knowledge-sharing from experts in the area of respiratory medicines and is an essential event for all those new to or experienced in inhalation drug delivery.

Inhaled drug delivery is achieved using four principal technologies: dry powder inhalers, metered-dose inhalers, nebulisers and liquid inhalers. Although there are many differences between these technologies, there are a number of fundamental principles that are followed to achieve an effective delivered dose. This event will provide an excellent forum to share knowledge and explore the opportunities across the dose forms with key industry leaders.

This programme will provide valuable insights into inhaled drug delivery from experts in the field and will give you:

  • A comprehensive update on the advances in inhalation technology and inhaled drug delivery
  • An opportunity to keep abreast of global trends
  • An excellent forum to discuss challenges and how to overcome them

Our media partner

Wilbur de Kruijf

More details

Jason Cheng

More details

Arnaud Guillet

More details

Mike Holroyd

Mike Holroyd is Senior Director with responsibility for the design, development and scale-up of inhalation devices within the Mylan Global Respiratory Group. He has an MA in Engineering from St. Catharine’s College, Cambridge. He started his career at Rolls-Royce Aero engines, before moving to PA consulting group where he was a Partner and manager of the product development group. He then joined Norton Healthcare in 1993, where he directed all inhalation device development, including engineering, formulation development and analytical laboratory services and the subcontract manufacture of devices. At Norton he developed, scaled-up and launched Easi-Breathe as well as developing the Spiromax MDPI. He was awarded the Royal Academy of Engineering MacRobert award for the development of Easi-Breathe.
He left Noton (now part of IVAX) to start his own consultancy business, before joining Phoqus Pharmaceuticals as Vice President Engineering to develop novel drug delivery systems based on electrostatic deposition technology. He then returned to consultancy, operating as Programme Director on a major new respiratory device development, until he joined Myland in 2013.

More details

David Jefferys

Dr David Jefferys is Senior Vice President for Global Regulatory, Government Relations, Public Affairs and Patient Safety (EMEA, Russia and Australasia) at Eisai. After qualifying, he worked in clinical and academic medicine before spending 20 years as a senior regulator for both medicines and medical devices.

He was executive director of the UK Medicines Control Agency, CEO and Director of the MDA and joint CEO of the MHRA. He was involved in the establishment of the European Medicines Agency, is a CPMP/CHMP member and Chair of the MRFG and PER scheme. For the last ten years he has worked in industry and chairs several key committees for ABPI,EFPIA and IFPMA.

More details

Alex Jezequel

More details

Paul Johnson

More details

Stefan Leiner

More details

Ronan MacLoughlin

More details

Steven Nichols

More details

Tomas Norling

More details

Tom Oakley

More details

John Pritchard

More details

Dana Shears

More details

Francesca Usberti

More details

Sam Van Alstyne

More details

Wim Vos

More details

We don't have any currently scheduled dates for this course but we can customise it to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.

See below or contact us to discuss yor requirements.

Reviews of IPI's Inhaled Drug Delivery training course


Very impressed with all speakers

Nov 13 2017

Peter Davies
Quality Engineer, Bespak Europe Ltd

Nov 13 2017

Generally really satisfied on terms of the content and speakers as well as the location.

Thierry Rousselot
Clinical Project Manager, Chiesi SAS

Nov 13 2017

Very engaging. good number of speakers

Kevin Chilvers
Senior Quality Engineer, Bespak Europe Ltd

Nov 13 2017

Very good

James Arnold
Assistant Editor, OnDrugDelivery Ltd

Nov 13 2017

Excellent content, valuable and knowledgable speakers. Liked it. Good.

Aravind Rambhau Sonawane
Manager, Business Development, Sunpharma Global

Nov 16 2016

Very worthwhile. Some good and valuable information.

Annmarie Gambrill
Device Analytical Scientist , Mylan Pharma UK Ltd

Nov 16 2016

Very good conference with plenty of time for networking and high level talks. I will recommend it to my colleagues.

Segolene Sarrailh
Lab Manager, Inhalation & new products, Aptar France

Nov 16 2016

Networking!

Elena Pasini
Scientist, Chiesi Farmaceutici S.p.a.

Nov 16 2016

Its a good mix of topics

Sunita Sule
Inhalator Products Consultant,

UK

  • 3M
  • 3M Health Care Limited
  • 3M Health Care Ltd
  • 3M Healthcare Ltd
  • 3P Innovation Limited
  • Aptar Pharma
  • ASTECH PROJECTS LTD
  • AstraZeneca R&D Charnwood
  • Bespak Europe Ltd
  • Boehringer Ingelheim Ltd
  • Cambridge Consultants Ltd
  • Cambridge Design Partnership
  • Cardiff Scintigraphics
  • Catalent Pharma Solutions
  • Chiesi Limited
  • Clement Clarke International
  • Coalesce Product Development
  • Copley Scientific Limited
  • Cranfield University
  • D H Industries Ltd
  • DCA Design International
  • DLRC
  • Dr Reddy's Laboratories (UK) Ltd
  • Dr Reddy's Laboratories Ltd
  • Exco InTouch Ltd
  • GlaxoSmithKline
  • GlaxoSmithKline Research & Development Ltd
  • H12 Consulting, UK
  • Harro Hoefliger Packaging Systems Ltd
  • Huntingdon Life Sciences
  • Imperial College
  • Innovata Biomed Ltd, Vectura Group Plc
  • Innovata Ltd (part of Vectura Group plc)
  • Kings College London
  • Malvern Instruments Ltd
  • Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Medicines Assessment Ltd
  • Mexichem UK Limited
  • MHRA
  • Molins Technologies
  • Mr Gordon Hutchinson
  • Mundipharma International Ltd
  • Mundipharma Research Ltd
  • Mylan
  • Mylan Pharma UK Ltd
  • Nanopharm
  • Novartis Pharmaceuticals UK Ltd
  • OnDrugDelivery Ltd
  • PA Consulting Group
  • Pfizer Limited
  • Pfizer Ltd
  • Pharma Delivery Solutions
  • PMT Particle Measuring Technique (GB) Ltd.
  • Presspart Manufacturing Ltd
  • Prosonix Limited
  • Proveris Scientific
  • Respironics Respiratory Drug Delivery (UK) Ltd
  • Respivert Ltd
  • Sagentia Limited
  • Sandoz Limited
  • Sanofi
  • Springboard
  • Springboard Pro Ltd.
  • Team Consulting Ltd
  • Technology Partnership Plc
  • Teva Pharmaceuticals Europe B.V.
  • Teva UK Limited
  • Trig1 Ltd
  • University of Greenwich
  • Vectura
  • Vectura Group Plc
  • Vectura Limited
  • Verona Pharma Plc

Germany

  • 3-S-Pharmacological Consultation & Research GmbH
  • Activaero GmbH
  • AEROPHARM GmbH
  • Almirall Sofotec GmbH
  • Bayer Pharma AG
  • Boehringer Ingelheim microParts GmbH
  • Boehringer Ingelheim Pharma GmbH & Co KG
  • Boehringer Ingelheim Pharma GmbH & Co. KG
  • Boehringer Ingelheim Vetmedica GmbH
  • Gerresheimer Regensburg GmbH
  • Harro Höfliger Verpackungsmaschinen GmbH
  • Helm AG
  • Immunservice GmbH
  • Johannes Gutenberg University
  • Mundipharma Research GmbH & Co. KG
  • Novaliq GmbH
  • Pharmazeutisches Institut der Universiat Kiel
  • Phillips-Medisize
  • Presspart GmbH & Co. KG
  • Rexam Pharma GmbH
  • Roche Diagnostics GmbH
  • RPC Formatec GmbH
  • Sandoz International GmbH
  • Schunk Carbon Technology
  • sfm medical devices GmbH
  • SGS Institut Fresenius GmbH
  • Siegfried Pharma Development GmbH
  • Sofotec GmbH
  • Zentiva Inhalationsprodukte GmbH

France

  • Aptar France
  • Aptar France SAS
  • APTAR FRANCE SAS (VALOIS SAS)
  • Aptar Pharma
  • Astrazeneca
  • Biocorp
  • Chiesi SAS
  • GlaxoWellcome Production
  • Rexam Dispensing Systems

Ireland

  • Health Products Regulatory Authority
  • Mylan Ireland Limited
  • Nypro Healthcare
  • Organon/Schering-Plough
  • SWORDS LABORATORIES LTD
  • TECH GROUP
  • Tech Group Europe
  • Teva Pharamceuticals

Italy

  • Chiesi Farmaceutici S.p.A
  • Chiesi Farmaceutici S.p.a.
  • Chiesi Farmaceutici SpA
  • Genetic SpA
  • Merck Serono SpA
  • MIAT SpA
  • PH&T SpA
  • Zambon SpA

Sweden

  • Astra Zeneca AB
  • AstraZeneca
  • AstraZeneca R & D Lund
  • Emmace Consulting AB
  • ICONOVO AB
  • McNeil AB
  • S5 Consulting
  • SHL Group AB

Switzerland

  • Forteq Healthcare
  • Komax Systems LCF SA
  • Novartis Pharma AG
  • Philip Morris International
  • Siegfried Ltd
  • SkyePharma AG
  • Valois Dispray SA

United States of America

  • Catalent Pharma Solutions
  • Cirrus Pharmaceuticals
  • MannKind Corporation
  • MAP Pharmaceuticals
  • Oriel Therapeutics Inc.
  • Sepracor Inc
  • Sunovion

Belgium

  • Argenx
  • Fluidda
  • Laboratoires SMB
  • Laboratoires SMB S.A.
  • UCB Pharma SA

Finland

  • Orion Corporation
  • Orion Corporation Orion Pharma
  • Oy Medfiles Ltd
  • Phillips-Medisize

China

  • Bering (Nanjing) Scientific Information Ltd
  • Bering Scientific Information Ltd
  • CF PharmTech

Netherlands

  • IGS Gebojagema
  • ProQR Therapeutics BV
  • University of Groningen

Spain

  • Almirall S.A.
  • Almirall SA
  • Laboratorios CINFA SA

Czech Republic

  • Teva Czech Industries S R O
  • Zentiva Group AS

Poland

  • LEK-AM Sp. z o.o.
  • Office for Registration of Medicinal Products, Medical Devices & Biocides

Canada

  • Tetra Bio Pharma

Denmark

  • Xellia Pharmaceuticals ApS

Egypt

  • EVA Pharma

Greece

  • ELPEN Pharmaceutical Co Inc

India

  • Dr Reddy's Laboratories Ltd

Israel

  • Omega Life Science

Japan

  • Tokyo University of Science

Jordan

  • Hikma Pharmaceuticals

Portugal

  • Hovione FarmaCiencia SA

Romania

  • SC Pharma Serv International Srl

United Arab Emirates

  • Sunpharma Global

Multiple colleagues?
Talk to one of our training experts to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Aleksandra BEER
Training expert

+44 (0)20 7749 4749

inhouse@ipi.academy